Carolyn Blackett

Generating Selective Leads for Mer Kinase Inhibitors—Example of a Comprehensive Lead-Generation Strategy

J. Willem M. Nissink, Sana Bazzaz, Carolyn Blackett et al. · Journal of Medicinal Chemistry · 2021 · 26 citations · Full text

Drug Target, Hit Identification, Mer Inhibitors +23

Enabling 1536-Well High-Throughput Cell-Based Screening through the Application of Novel Centrifugal Plate Washing

Sinéad Knight, Helen Plant, Lisa McWilliams et al. · SLAS DISCOVERY · 2017 · 20 citations · Full text

Engineering, Biofabrication, Biomedical Engineering +21

An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode

Nicholas Larsen, Tory J. Nash, Marshall Morningstar et al. · Biochemical Journal · 2012 · 18 citations

Aminoquinazoline Inhibitor, Crystal Structure, Inhibitory Activity +13

The Role of Historical Bioactivity Data in the Deconvolution of Phenotypic Screens

Aurélie Bornot, Carolyn Blackett, Ola Engkvist et al. · SLAS DISCOVERY · 2014 · 12 citations · Full text

High throughput screening of 0.5 million compounds against CRAF using Alpha CETSAⓇ

Hannah Rowlands, Kirsten Tschapalda, Carolyn Blackett et al. · SLAS DISCOVERY · 2023 · 12 citations · Full text